FURIN and psoriasis: Furthermore, it appears that dithranol treatment can sustainably normalize furin expression in patients with moderate to severe psoriasis, provided the disease remains improved as observed by PASI reduction of 58.1% (from 13.6 to 5.7) 4–6 weeks after end of treatment (Figure 1).